Skip to content
TrialScanner

NCT03263091

Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden

Phase 3TerminatedKYNBLeadAZNCollaborator

Registry record

Lead sponsor
Kyntra Bio
Conditions
Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts); Anemia
Primary completion
Mar 9, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03263091 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03263091: Efficacy and Safety of... | TrialScanner